@pharmoinstitute.bsky.social
Happy New Year to all of our passionate, collaborative, and enthusiastic clients, staff, and followers.
We are excited for the start of the new year and look forward to working with all of you in 2026!
#NewYears #NewYears2026 #HappyNewYear
We are excited for the start of the new year and look forward to working with all of you in 2026!
#NewYears #NewYears2026 #HappyNewYear
January 2, 2026 at 1:30 PM
Happy New Year to all of our passionate, collaborative, and enthusiastic clients, staff, and followers.
We are excited for the start of the new year and look forward to working with all of you in 2026!
#NewYears #NewYears2026 #HappyNewYear
We are excited for the start of the new year and look forward to working with all of you in 2026!
#NewYears #NewYears2026 #HappyNewYear
ICYMI a recent #PrimaryCare #Diabetes study underlines the importance of further research into the underlying causes of #glycaemic control disparities and the development of tailored interventions to optimise #T2D care for all buff.ly/sQaz2P3
#Type2Diabetes #HealthEquity
#Type2Diabetes #HealthEquity
December 29, 2025 at 6:30 PM
ICYMI a recent #PrimaryCare #Diabetes study underlines the importance of further research into the underlying causes of #glycaemic control disparities and the development of tailored interventions to optimise #T2D care for all buff.ly/sQaz2P3
#Type2Diabetes #HealthEquity
#Type2Diabetes #HealthEquity
Generating #RWE in #SpinalMuscularAtrophy (#SMA) faces hurdles with evolving standard of care, inconsistent outcomes measurement, severity baseline, and the need for long-term follow-up. Test your objectives with us: buff.ly/Qj6Z6Uq
#HCRU #SpinalCare #RealWorldEvidence
#HCRU #SpinalCare #RealWorldEvidence
December 15, 2025 at 1:01 PM
Generating #RWE in #SpinalMuscularAtrophy (#SMA) faces hurdles with evolving standard of care, inconsistent outcomes measurement, severity baseline, and the need for long-term follow-up. Test your objectives with us: buff.ly/Qj6Z6Uq
#HCRU #SpinalCare #RealWorldEvidence
#HCRU #SpinalCare #RealWorldEvidence
Season's greetings from PHARMO, part of Lumanity!
We wish you and your loved ones a peaceful, bright, and joyous season.
We wish you and your loved ones a peaceful, bright, and joyous season.
December 10, 2025 at 4:09 PM
Season's greetings from PHARMO, part of Lumanity!
We wish you and your loved ones a peaceful, bright, and joyous season.
We wish you and your loved ones a peaceful, bright, and joyous season.
#Sinterklaas is celebrated in the Netherlands on December 5, a holiday where creativity plays a key role and is all about bringing people together and creating a warm, festive atmosphere. Yesterday our Utrecht celebrated with second hand gifts and a dice game! #FijneSinterklaas
December 5, 2025 at 8:00 AM
#Sinterklaas is celebrated in the Netherlands on December 5, a holiday where creativity plays a key role and is all about bringing people together and creating a warm, festive atmosphere. Yesterday our Utrecht celebrated with second hand gifts and a dice game! #FijneSinterklaas
A recent study in #PrimaryCare #Diabetes underlines the importance of further research into the underlying causes of #glycaemic control disparities and the development of tailored interventions to optimise #T2D care for all. buff.ly/sQaz2P3
#Type2Diabetes #HealthEquity
#Type2Diabetes #HealthEquity
December 4, 2025 at 8:00 AM
A recent study in #PrimaryCare #Diabetes underlines the importance of further research into the underlying causes of #glycaemic control disparities and the development of tailored interventions to optimise #T2D care for all. buff.ly/sQaz2P3
#Type2Diabetes #HealthEquity
#Type2Diabetes #HealthEquity
Check out this article using the PHARMO Data Network to conduct a #retrospective, #observational cohort study to assess a number of clinically relevant endpoints in patients in the Netherlands with #T2D. buff.ly/mSfkk3P
#Type2Diabetes #Diabetes #RWE #Semaglutide
#Type2Diabetes #Diabetes #RWE #Semaglutide
December 3, 2025 at 8:00 AM
Check out this article using the PHARMO Data Network to conduct a #retrospective, #observational cohort study to assess a number of clinically relevant endpoints in patients in the Netherlands with #T2D. buff.ly/mSfkk3P
#Type2Diabetes #Diabetes #RWE #Semaglutide
#Type2Diabetes #Diabetes #RWE #Semaglutide
ICYMI, our latest whitepaper explores the growing need for #EvidenceTransportability. Dive into common use cases, challenges in applying non-local data, and our structured framework: buff.ly/LCS7MjB
#RWE #HTA #JCA #StakeholderEngagement #DataValidation
#RWE #HTA #JCA #StakeholderEngagement #DataValidation
November 26, 2025 at 11:01 AM
ICYMI, our latest whitepaper explores the growing need for #EvidenceTransportability. Dive into common use cases, challenges in applying non-local data, and our structured framework: buff.ly/LCS7MjB
#RWE #HTA #JCA #StakeholderEngagement #DataValidation
#RWE #HTA #JCA #StakeholderEngagement #DataValidation
Our latest whitepaper explores the growing need for #EvidenceTransportability, use cases, challenges in applying non-local data, and our framework to effectively assess and enable it buff.ly/LCS7MjB
#RWE #HTA #JCA #StakeholderEngagement #DataValidation
#RWE #HTA #JCA #StakeholderEngagement #DataValidation
November 17, 2025 at 12:02 PM
Our latest whitepaper explores the growing need for #EvidenceTransportability, use cases, challenges in applying non-local data, and our framework to effectively assess and enable it buff.ly/LCS7MjB
#RWE #HTA #JCA #StakeholderEngagement #DataValidation
#RWE #HTA #JCA #StakeholderEngagement #DataValidation
Our latest co-authored publication using #GPData from the PHARMO Data Network, investigates the incidence and natural course of #SHT in #PrimaryCare and assesses guideline adherence and recommendations in Dutch primary care pubmed.ncbi.nlm.nih.gov/41196264/
#Epidemiology #Hyperthyroidism
#Epidemiology #Hyperthyroidism
Natural course of subclinical hyperthyroidism In primary care in the Netherlands - PubMed
This study highlights that a small subset of SHT patients progress to overt hyperthyroidism. Factors increasing the odds for progression included lower baseline TSH and female sex. Our findings…
pubmed.ncbi.nlm.nih.gov
November 10, 2025 at 3:40 PM
Our latest co-authored publication using #GPData from the PHARMO Data Network, investigates the incidence and natural course of #SHT in #PrimaryCare and assesses guideline adherence and recommendations in Dutch primary care pubmed.ncbi.nlm.nih.gov/41196264/
#Epidemiology #Hyperthyroidism
#Epidemiology #Hyperthyroidism
#ISPOREurope2025 is just days away! Meet with our #RWE experts and discover how leveraging the PHARMO data network can strengthen your HTA submissions with robust, real world insights. buff.ly/z6680ml
#ISPOREurope #HEOR #HealthEconomics #HTA #RWE #RWD
#ISPOREurope #HEOR #HealthEconomics #HTA #RWE #RWD
November 7, 2025 at 10:01 AM
#ISPOREurope2025 is just days away! Meet with our #RWE experts and discover how leveraging the PHARMO data network can strengthen your HTA submissions with robust, real world insights. buff.ly/z6680ml
#ISPOREurope #HEOR #HealthEconomics #HTA #RWE #RWD
#ISPOREurope #HEOR #HealthEconomics #HTA #RWE #RWD
Download our new paper to explore the growing need for #EvidenceTransportability, common use cases, the challenges in applying non-local data, and our structured framework. buff.ly/LCS7MjB
#RWE #EvidenceTransportability #HTA #JCA #StakeholderEngagement #DataValidation
#RWE #EvidenceTransportability #HTA #JCA #StakeholderEngagement #DataValidation
November 6, 2025 at 8:15 AM
Download our new paper to explore the growing need for #EvidenceTransportability, common use cases, the challenges in applying non-local data, and our structured framework. buff.ly/LCS7MjB
#RWE #EvidenceTransportability #HTA #JCA #StakeholderEngagement #DataValidation
#RWE #EvidenceTransportability #HTA #JCA #StakeholderEngagement #DataValidation
Will you be at #ISPOREurope2025? If so, be sure to catch our poster presentations and connect with our colleagues on-site! Schedule a meeting with us: buff.ly/kvJzMV0
#ISPOREurope #HEOR #HealthEconomics #HTA #RWE #ObservationalStudies #RWD
#ISPOREurope #HEOR #HealthEconomics #HTA #RWE #ObservationalStudies #RWD
November 3, 2025 at 10:45 AM
Will you be at #ISPOREurope2025? If so, be sure to catch our poster presentations and connect with our colleagues on-site! Schedule a meeting with us: buff.ly/kvJzMV0
#ISPOREurope #HEOR #HealthEconomics #HTA #RWE #ObservationalStudies #RWD
#ISPOREurope #HEOR #HealthEconomics #HTA #RWE #ObservationalStudies #RWD
PHARMO has been addressing design and data biases and applying the #TargetTrialEmulation (#TTE) framework for 25+ years. buff.ly/YsgKNaz
Let's discuss how we can solve your research needs, and be sure to catch us at #ISPOREU2025!
#ObservationalStudies #RCTs #RWE #RWD
Let's discuss how we can solve your research needs, and be sure to catch us at #ISPOREU2025!
#ObservationalStudies #RCTs #RWE #RWD
October 29, 2025 at 10:30 AM
PHARMO has been addressing design and data biases and applying the #TargetTrialEmulation (#TTE) framework for 25+ years. buff.ly/YsgKNaz
Let's discuss how we can solve your research needs, and be sure to catch us at #ISPOREU2025!
#ObservationalStudies #RCTs #RWE #RWD
Let's discuss how we can solve your research needs, and be sure to catch us at #ISPOREU2025!
#ObservationalStudies #RCTs #RWE #RWD
Attending the World Vaccine Congress Europe in Amsterdam this week?
Be sure to connect with our colleague Josine Kuiper while at the congress. Learn more at www.terrapinn.com/conference/w...
#WVCEU #WorldVaccineCongress #Vaccines #Biotech
Be sure to connect with our colleague Josine Kuiper while at the congress. Learn more at www.terrapinn.com/conference/w...
#WVCEU #WorldVaccineCongress #Vaccines #Biotech
October 13, 2025 at 4:50 PM
Attending the World Vaccine Congress Europe in Amsterdam this week?
Be sure to connect with our colleague Josine Kuiper while at the congress. Learn more at www.terrapinn.com/conference/w...
#WVCEU #WorldVaccineCongress #Vaccines #Biotech
Be sure to connect with our colleague Josine Kuiper while at the congress. Learn more at www.terrapinn.com/conference/w...
#WVCEU #WorldVaccineCongress #Vaccines #Biotech
In the Netherlands, an estimated 1,500–2,000 individuals are living with #SickleCellDisease (SCD), yet there's limited #RealWorldData on the clinical burden, especially regarding recurrent vaso-occlusive crisis. Learn more at buff.ly/5PNBMxr
#SickleCellAwareness #RWE
#SickleCellAwareness #RWE
October 9, 2025 at 11:16 PM
In the Netherlands, an estimated 1,500–2,000 individuals are living with #SickleCellDisease (SCD), yet there's limited #RealWorldData on the clinical burden, especially regarding recurrent vaso-occlusive crisis. Learn more at buff.ly/5PNBMxr
#SickleCellAwareness #RWE
#SickleCellAwareness #RWE
Will you be at the World Vaccine Congress Europe in Amsterdam?
If so, be sure to reach out to Josine Kuiper or email contact@lumanity.com to connect while at the conference. Learn more at www.terrapinn.com/conference/w...
#WVCEU #WorldVaccineCongress #Vaccines #Biotech
If so, be sure to reach out to Josine Kuiper or email contact@lumanity.com to connect while at the conference. Learn more at www.terrapinn.com/conference/w...
#WVCEU #WorldVaccineCongress #Vaccines #Biotech
September 30, 2025 at 11:53 PM
Will you be at the World Vaccine Congress Europe in Amsterdam?
If so, be sure to reach out to Josine Kuiper or email contact@lumanity.com to connect while at the conference. Learn more at www.terrapinn.com/conference/w...
#WVCEU #WorldVaccineCongress #Vaccines #Biotech
If so, be sure to reach out to Josine Kuiper or email contact@lumanity.com to connect while at the conference. Learn more at www.terrapinn.com/conference/w...
#WVCEU #WorldVaccineCongress #Vaccines #Biotech
#TargetTrialEmulation (#TTE) framework can be applied to #ObservationalStudies to emulate the conditions and protocol of an ideal hypothetical #RCT, addressing sources of bias. Learn more about how PHARMO has been doing this for 25+ years. buff.ly/YsgKNaz #RWE #RWD
September 25, 2025 at 2:30 PM
#TargetTrialEmulation (#TTE) framework can be applied to #ObservationalStudies to emulate the conditions and protocol of an ideal hypothetical #RCT, addressing sources of bias. Learn more about how PHARMO has been doing this for 25+ years. buff.ly/YsgKNaz #RWE #RWD